Skip to main content
. 2018 Sep 15;10(9):2975–2989.

Figure 1.

Figure 1

Flow cytometric analysis for measuring the circulatory endothelial progenitor cells and hematopoietic stem cells (n=9). (A, B) Illustrating the circulating level of CD34+KDR+CD45dim cells prior to (A) and after (B) G-CSF treatment. (C) Analytical result, * vs. †, P<0.001. (D, E) Illustrating the circulating level of CD34+CD133+CD45dim cells prior to (D) and after (E) G-CSF treatment. (F) Analytical result, * vs. †, P<0.001. (G, H) Illustrating the circulating level of CD34+CD133+KDR+ cells prior to (G) and after (H) G-CSF treatment. (I) Analytical result, * vs. †, P<0.01. (J, K) Illustrating the circulating level of CD31+CD133+CD45dim cells prior to (J) and after (K) G-CSF treatment. (L) Analytical result, * vs. †, P<0.01. (M, N) Illustrating the circulating level of CD34+ cells prior to (M) and after (N) G-CSF treatment. (O) Analytical result, * vs. †, P<0.01. (P, Q) Illustrating the circulating level of CD133+ cells prior (P) and after (Q) G-CSF treatment. (R) Analytical result, * vs. †, P<0.001. G-CSF = granulocyte colony stimulating factor.